Answers are grounded in this paper and cite their sources.
Evaluates posttransfusion iron overload and systemic complications in hemoglobinopathy patients, suggesting urgent need for monitoring.
Background: Transfusion-dependent hemoglobinopathies such as β-thalassaemia major and sickle cell disease require lifelong or recurrent blood transfusions, predisposing patients to progressive iron overload and multi-organ complications. In resource-limited settings, inadequate monitoring and poor chelation adherence contribute substantially to morbidity and healthcare burden. Aim and Objectives: To estimate the prevalence and severity of posttransfusion iron overload and to evaluate its association with systemic complications and direct medical costs among transfusion-dependent hemoglobinopathy patients in central India. Materials and Methods: A hospital-based analytical cross-sectional study was conducted over 2 years (May 2019–April 2021) at a tertiary care teaching hospital in central India. A total of 456 transfusion-dependent patients with β-thalassaemia major or sickle cell disease were included. Iron overload was defined as serum ferritin ≥1000 µg/L in the presence of normal C-reactive protein and categorized as mild (1000–2499 µg/L), moderate (2500–4999 µg/L), or severe (≥5000 µg/L). Hepatic, endocrine, cardiac, and renal complications were assessed using clinical and laboratory parameters. Multivariable logistic regression analysis was performed to identify factors independently associated with systemic complications. Results: Iron overload was present in 427 patients (93.6%), with 315 patients (69.0%) demonstrating moderate-to-severe overload. Severe iron overload was more common among patients with β-thalassaemia major than sickle cell disease. Hepatic dysfunction, diabetes mellitus, cardiac abnormalities, and renal impairment were observed in 35.5%, 10.3%, 19.3%, and 11.4% of patients, respectively. Increasing iron overload severity showed significant graded associations with all major systemic complications. Severe iron overload independently predicted hepatic dysfunction (aOR]4.8; 95% CI: 2.9–7.9), diabetes mellitus (aOR 3.2; 95% CI: 1.7–6.0), cardiac abnormalities (aOR 2.7; 95% CI: 1.6–4.5), and renal impairment (aOR 2.3; 95% CI: 1.3–4.1). Irregular or absent chelation therapy was consistently associated with higher complication risk. Median 6-month direct medical costs increased progressively from INR 32,000 in patients with no/mild overload to INR 78,000 in those with severe overload. Conclusion: Posttransfusion iron overload is highly prevalent among transfusion-dependent hemoglobinopathy patients in central India and is strongly associated with significant hepatic, endocrine, cardiac, and renal morbidity, along with increased healthcare costs. Early detection, routine ferritin-based monitoring, and improved long-term chelation adherence are essential to reduce preventable complications and healthcare burden in resource-limited settings.
No takes yet. Share an insight, caveat, or question.
Kesharwani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: